In the article by Okunrintemi et al, “Patient–Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States Medical Expenditure Panel Survey 2010 to 2013,” which appeared in the April 2017 issue of the journal (Circ Cardiovasc Qual Outcomes. 2017;10:e003635), a correction was needed.
The Disclosures statement has been revised to read:
Dr Nasir is on the advisory board for Quest Diagnostic and a consultant for Regeneron. Dr Krumholz has research agreements with Medtronic and Johnson & Johnson through his institution; is a member of the scientific advisory board for UnitedHealth; and is founder of Hugo.
The authors regret this error.
This correction has been made to the article, which is available at http://circoutcomes.ahajournals.org/content/10/4/e003635.
- © 2017 American Heart Association, Inc.